Surgery planning software co-developed by NuVasive earns FDA nod

Software, Machines and Adaptative Implants in Orthopaedics recieved FDA 510(k) clearance for its custom surgery planning software developed with NuVasive.

Advertisement

The software is designed for joint surgery and is based on SMAIO’s Balance Anaylzer 3D software, according to a June 8 company news release.

SMAIO and NuVasive initially partnered in 2022. Under the partnership terms, NuVasive will pay $3 million to SMAIO after this milestone. The companies plan to integrate the Balance Analyzer 3D into NuVasive’s platform.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Is ambulatory care healthcare’s big margin engine? 4 leaders weigh in

Wednesday, July 29
1:00 PM - 2:00 PM CDT

Presenters: Joe Ganley, athenahealthJeffrey Flynn, CASC, Gramercy Surgery CenterBryan Tsao, Access Center, Loma Linda University HealthJason Zepeda, Northridge Hospital Medical Center, CommonSpirit HealthGreg DeConciliis, PA-C, CASC, Boston Out­Patient Surgical Suites

Advertisement

Next Up in Orthopedic

Advertisement

Comments are closed.